CYP2C19 and neoplasm: The combination in donor of GG variant in ABCC2 rs2273697 with AG or AA variants in rs4244285 of CYP2C19 metabolizer gene could reduce the risk of tumor occurrence, with an OR < 0.2 in both cases.